As per the GOI circular on price capping of Orthopaedic Knee implant by NPPA(National Pharmaceutical Pricing Authority), new prices of knee implants have been implemented effective 16th August 2017. For details on knee implant pricing across our hospitals. CLICK HERE | As per GOI’s circular on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents have been implemented effective 14th February, 2017. For details on stent pricing, across our hospitals. CLICK HERE

About Us

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Dubai, Mauritius and Sri Lanka with 45 healthcare facilities (including projects under development), approximately 10,000 potential beds and 314 diagnostic centres.

In a global study of the 30 most technologically advanced hospitals in the world, its flagship, the Fortis Memorial Research Institute’ (FMRI), was ranked No.2, by ‘, and placed ahead of many other outstanding medical institutions in the world.

About Us

VisionMissionValuesThe BrandMessage From Executive ChairmanBoard Of DirectorsManagement Team

Malvinder Mohan Singh

Executive Chairman, Fortis Healthcare Limited


Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.

With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.

In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.

With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.

In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.

Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts.

Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.

Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.

Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.

Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.


Shivinder Mohan Singh

Non Executive Vice Chairman, Fortis Healthcare Limited


Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Non - Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.

Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.

Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).

While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.

Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films! .


Harpal Singh

Harpal Singh is Mentor & Chairman Emeritus, Fortis Healthcare Limited


Harpal Singh is recognized worldwide as a thinker and speaker on the integration of global healthcare. He has a diverse and wide-ranging experience (of over 35 years) in the corporate sector.

Currently he is the Mentor & Chairman Emeritus and a member of the Board of Directors of Fortis Healthcare Limited, Fortis Clinical Research Limited, Religare Enterprises Ltd., and SRL Diagnostics Ltd. He is also Director of Impact Projects Private Ltd and Impact Senior Living Estates Private Limited. He was Non Executive Chairman of India’s largest Pharmaceutical Company, Ranbaxy

He is and has been associated at the Board level with some of India’s most renowned schools which include The Doon School, The Scindia School, The Shriram School, The Yadavindra Public Schools and Salwan Public Schools.  He was a member of the National Round Table on School Education, a member of the Executive Committee and of the Governing Council of Public Health Foundation of India (PHFI), a member of the Board of the Delhi Red Cross Society, a member of the Board of Governors of NIIT University, a member of India-UK Round Table and India-US Strategic dialogue.  He is a Trustee of Indian National Association for the Club of Rome. He is a Member of the Board of Wadhwani Initiative for Sustainable Health (WISH).  He is Founder and Chairman of Nanhi Chhaan Foundation. He was also a member of the Board of Governors of IIT, Indore. Currently he is the Chairman, Save the Children India and Vice Chair, Save the Children International, UK.


An alumnus of The Doon School and an (Hons.) Graduate in Economics from St. Stephens College, New Delhi. A B.S. in Economics and a Masters' in Public Affairs from the California State University at Hayward (C.S.C.H.), California, U.S.A.


Dr. Brian W Tempest


Dr. Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade.

Brian is currently Editor of the Journal of Generic Medicines and a Non Executive Director of the United Nations Medicines Patent Pool in Geneva, Switzerland representing the global generic industry.

Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional Director, President, Managing Director and Chief Executive Officer until 2005 when Ranbaxy became the 9th largest Global Generic Pharmaceutical Company. He then became Chief Mentor, Vice Chairman and Non Executive Director until 2008 when he retired. He is one of the few Westerners to have led a Sensex Nifty 50 Indian blue chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director-Far East and Regional Director-Middle East & Africa from 1985 to 1992.

He has worked in the Pharmaceutical Industry for the last 43 years and has managed Healthcare Businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India and has led many sessions at Investor Meetings held around the world from Tokyo to Las Vegas.

Brian is a Non Executive Director of Religare Capital Markets, SRL Diagnostics Limited, Fortis Healthcare and Glenmark Pharmaceuticals Ltd. Brian speaks at global conferences on the structural changes in the Global Pharmaceutical Marketplace and most of his presentations in the last decade are available on

Brian received a PhD in Chemistry from Lancaster University, UK in 1971 and in 2009 he became Chairman of the Advisory Board for the Lancaster University Management School. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Medicine.


Dr. P. S. Joshi


Dr. Preetinder Singh Joshi, an eminent Cardiologist, holds an MBBS degree in Medicine from Medical College, Amritsar (Punjab University, Chandigarh 1970) and MD degree in Cardiology & General Medicine from Maulana Azad Medical College (Delhi University 1974). (He stood first in the University and was declared best graduate of Medical College, Amritsar). He became a member of Royal College of Physicians, UK (MRCP) in 1978.

He is a Fellow of American College of Cardiology (FACC), Fellow Royal College of Physicians Edinburgh (FRCP) and Fellow Cardiological Society of India. He has over 40 years of experience in medical profession in India and abroad. He has held many positions of responsibility including Directorship and Head, Department of Medicine & Cardiology Divisions in Escorts Medical Centre (1981-84), Birla Centre for Medical Research, New Delhi (1984-85) & Maharaj Sawan Singh Charitable Hospital, Beas (1985-till date).


Joji Sekhon Gill


Joji Sekhon Gill is the Regional Director of Human Resources, Asia Pacific, DuPont.  In this role, she is responsible for talent Strategy for the APAC region. She joined DuPont on August 1, 2012 as the Strategic HR Director for DuPont South Asia.

Prior to this, Joji was the Senior Director for Human Resources for Microsoft India since April 2006. At Microsoft she was responsible for driving the overall people strategy and building synergies for all the six Microsoft businesses in India. Microsoft has more than 6000 full time employees in India.

Joji has more than 25 years of Global HR expertise and has lived and worked in 3 different continents US, Europe and Asia, worked primarily in the US where she spent 15 years.

Joji holds a Bachelor’s Degree in Economics and a Masters in Personnel Management and Industrial Relations from Punjab University.



Pradeep Ratilal Raniga


Pradeep Ratilal Raniga has rich experience of over 30 years in the fields of accounting, taxation, legal structures, asset protection, financial planning, and financing. Currently, he also serves as a Financial Consultant to various companies in Australia, a country to which he migrated in 1985, from South Africa.

Prior to branching out independently, Pradeep was with HLB Mann Judd, Melbourne, rising to Partner and Member of the firm's Executive Committee. Before that he was a Partner at Farrar Jeena & Company, South Africa.

Pradeep has a Bachelors degree in Commerce from the University of Durban Westville, South Africa, and a Post-Graduate Diploma in Accounting from the University of Natal, South Africa. He has qualified as a Chartered Accountant in South Africa and is also a member of the Australian Institute of Chartered Accountants.


Ms. Shradha Suri Marwah


Ms.  Shradha Suri Marwah is a Post Graduate from The London School of Economics.

She is part of The Suri Group, which has interests in a diverse range of businesses ranging from Automotive Air-conditioner, Hospitality, Precision Component Manufacturing and Telecom to Education

She is having over 14 years of experience and she is Managing Director of Subros Limited, where she has been a critical part of Change Management and taken the company to new heights. Her key focus areas being creation of a strong R&D, HR, Quality and IT systems enabling decision support.

As a Young Entrepreneur & Visionary Leader, she also drives the Telecom Business of the group where the company (a telecom solutions provider) is engaged in design and manufacturing of access and optical networking equipments.


Request an Media Interaction

  1. Ms. Lynette Joy Hepburn Brown has resigned from the Company with effect from April 11, 2017.
  2. Mr. Ravi Umesh Mehrotra has resigned from the Company with effect from April 12, 2017.
  3. Mr. Sunil Godhwani has vacated his office of director with effect from August 4, 2017.